Astrazeneca (AZN) Change in Acquisitions & Divestments (2010 - 2026)

Astrazeneca's Change in Acquisitions & Divestments history runs 16 years deep, the most recent figure standing at -$85.0 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 8600.0% year-over-year to -$85.0 million; the TTM figure through Mar 2026 stood at $45.0 million (down 48.86% YoY), while the FY2025 annual figure was $131.0 million, up 336.67% from the prior year.
• Change in Acquisitions & Divestments was -$85.0 million for Q1 2026 at Astrazeneca, down from $9.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $114.0 million in Q2 2025 to a low of -$85.0 million in Q1 2026.
• Historically, Change in Acquisitions & Divestments has averaged $13.5 million across 5 years, with a median of $9.0 million in 2023.
• The sharpest annual moves came in 2023 and 2026: Change in Acquisitions & Divestments jumped 775.0% in 2023, then plunged 8600.0% in 2026.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at -$12.0 million in 2022, then surged by 775.0% to $81.0 million in 2023, then sank by 145.68% to -$37.0 million in 2024, then surged by 124.32% to $9.0 million in 2025, then tumbled by 1044.44% to -$85.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at -$85.0 million (Q1 2026), $9.0 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.